summary
Introduced
01/27/2020
01/27/2020
In Committee
03/09/2020
03/09/2020
Crossed Over
03/09/2020
03/09/2020
Passed
Dead
03/14/2020
03/14/2020
Introduced Session
2020 Regular Session
Bill Summary
An act relating to prescription drug price transparency; amending s. 110.12315, F.S.; requiring the Department of Management Services to contract for an annual audit of any pharmacy benefit vendor contracted under the state employees' prescription drug program; providing requirements for such audit; amending s. 499.012, F.S.; providing that permits for prescription drug manufacturers and nonresident prescription drug manufacturers are subject to specified requirements; creating s. 499.026, F.S.; providing definitions; requiring prescription drug manufacturers to provide notification of drug price increases to insurers; providing requirements for such notification; requiring prescription drug manufacturers to provide an annual report on drug price increases to the Department of Business and Professional Regulation and the Office of Insurance Regulation; providing reporting requirements; creating s. 624.491, F.S.; providing timelines and documentation requirements for pharmacy audits conducted by certain health insurers, health maintenance organizations, or their agents; providing that such requirements do not apply to audits in which certain conditions are met; creating s. 627.42394, , Engrossed 1 F.S.; requiring certain health insurers to establish a single point of contact for manufacturers to report drug price increases; requiring the Office of Insurance Regulation to maintain and publish a list of such contacts; requiring certain health insurers to provide written notice to insureds in advance of formulary changes resulting from manufacturer drug price increases; providing applicability; amending ss. 627.64741 and 627.6572, F.S.; providing definitions; requiring reporting requirements in contracts between health insurers and pharmacy benefit managers; requiring health insurers to submit an annual report to the office; requiring the office to publish such reports and analyses of specified information; authorizing the office to review contracts; authorizing the office to order health insurers to terminate contracts with pharmacy benefit managers under certain circumstances; providing rulemaking authority; revising applicability; creating s. 641.3131, F.S.; requiring certain health maintenance organizations to establish a single point of contact for manufacturers to report drug price increases; requiring the office to maintain and publish a list of such contacts; requiring certain health maintenance organizations to provide written notice to subscribers , Engrossed 1 in advance of formulary changes resulting from manufacturer drug price increases; providing applicability; amending s. 641.314, F.S.; providing definitions; requiring reporting requirements in contracts between health maintenance organizations and pharmacy benefit managers; requiring health maintenance organizations to submit an annual report to the office; requiring the office to publish such reports and analyses of specified information; authorizing the office to review contracts; authorizing the office to order health maintenance organizations to terminate contracts with pharmacy benefit managers under certain circumstances; providing rulemaking authority; revising applicability; requiring the Agency for Health Care Administration to contract for an independent analysis of pharmacy benefit management practices under the Statewide Medicaid Managed Care program; providing requirements for such analysis; providing definitions; requiring the agency to submit the analysis to the Governor and the Legislature; requiring the agency to conduct an analysis of managed care plan pharmacy networks and to analyze the composition of the networks under the Statewide Medicaid Managed Care program; providing requirements for such analysis; , Engrossed 1 providing definitions; requiring the agency to submit the analysis to the Governor and the Legislature; providing severability; providing severability; providing an effective date.
AI Summary
This bill aims to increase prescription drug price transparency in Florida. Key provisions include:
- Requiring the Department of Management Services to conduct an annual audit of any pharmacy benefit vendors contracted under the state employees' prescription drug program to ensure compliance with contract terms related to pharmaceutical rebates and spread pricing.
- Requiring prescription drug manufacturers to provide at least 60 days' notice to health insurers of any drug price increases of 15% or more for brand-name drugs costing $50+ for a 30-day supply, or 25% or more for generic/biosimilar drugs costing $25+ for a 30-day supply. Manufacturers must also submit annual reports on these price increases.
- Establishing requirements and timelines for pharmacy audits conducted by health insurers and HMOs, including notice periods, scope limitations, and reimbursement policies.
- Requiring health insurers and HMOs to establish a single point of contact for manufacturers to report drug price increases, maintain and publish lists of these contacts, and provide advance notice to policyholders of any resulting formulary changes.
- Expanding reporting requirements for contracts between health insurers/HMOs and pharmacy benefit managers, including details on rebates, administrative fees, and spread pricing. The Office of Insurance Regulation must analyze and publish this data annually.
The bill also requires the Agency for Health Care Administration to conduct independent analyses of pharmacy benefit management practices and managed care plan pharmacy networks under the Statewide Medicaid Managed Care program.
Committee Categories
Budget and Finance, Business and Industry, Health and Social Services
Sponsors (4)
Other Sponsors (2)
Health and Human Services Committee (House), Health Market Reform Subcommittee (House)
Last Action
Died in Banking and Insurance (on 03/14/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.flsenate.gov/Session/Bill/2020/7045 |
| Bill | https://www.flsenate.gov/Session/Bill/2020/7045/BillText/e1/PDF |
| Bill | https://www.flsenate.gov/Session/Bill/2020/7045/BillText/c1/PDF |
| House Committee Amendment #882603 to Amendment (917373) | https://www.flsenate.gov/Session/Bill/2020/7045/Amendment/882603/PDF |
| House Committee Amendment #917373 | https://www.flsenate.gov/Session/Bill/2020/7045/Amendment/917373/PDF |
| House Committee Amendment #342715 to Amendment (917373) | https://www.flsenate.gov/Session/Bill/2020/7045/Amendment/342715/PDF |
| Bill | https://www.flsenate.gov/Session/Bill/2020/7045/BillText/Filed/PDF |
Loading...